Literature DB >> 21039463

Rat eosinophils stimulate the expansion of Cryptococcus neoformans-specific CD4(+) and CD8(+) T cells with a T-helper 1 profile.

Ana P Garro1, Laura S Chiapello, José L Baronetti, Diana T Masih.   

Abstract

Experimental Cryptococcus neoformans infection in rats has been shown to have similarities with human cryptococcosis, revealing a strong granulomatous response and a low susceptibility to dissemination. Moreover, it has been shown that eosinophils are components of the inflammatory response to C. neoformans infections. In this in vitro study, we demonstrated that rat peritoneal eosinophils phagocytose opsonized live yeasts of C. neoformans, and that the phenomenon involves the engagement of FcγRII and CD18. Moreover, our results showed that the phagocytosis of opsonized C. neoformans triggers eosinophil activation, as indicated by (i) the up-regulation of major histocompatibility complex (MHC) class I, MHC class II and costimulatory molecules, and (ii) an increase in interleukin (IL)-12, tumour necrosis factor-α (TNF-α) and interferon-γ (IFN-γ) production. However, nitric oxide (NO) and hydrogen peroxide (H(2) O(2) ) synthesis by eosinophils was down-regulated after interaction with C. neoformans. Furthermore, this work demonstrated that CD4(+) and CD8(+) T lymphocytes isolated from spleens of infected rats and cultured with C. neoformans-pulsed eosinophils proliferate in an MHC class II- and class I-dependent manner, respectively, and produce important amounts of T-helper 1 (Th1) type cytokines, such as TNF-α and IFN-γ, in the absence of T-helper 2 (Th2) cytokine synthesis. In summary, the present study demonstrates that eosinophils act as fungal antigen-presenting cells and suggests that C. neoformans-loaded eosinophils might participate in the adaptive immune response.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21039463      PMCID: PMC3050441          DOI: 10.1111/j.1365-2567.2010.03351.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  49 in total

Review 1.  Mechanisms of phagocytosis in macrophages.

Authors:  A Aderem; D M Underhill
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

2.  Cryptococcus neoformans inhibits nitric oxide production by murine peritoneal macrophages stimulated with interferon-gamma and lipopolysaccharide.

Authors:  K Kawakami; T Zhang; M H Qureshi; A Saito
Journal:  Cell Immunol       Date:  1997-08-25       Impact factor: 4.868

3.  Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to Cryptococcus neoformans.

Authors:  G B Huffnagle; G B Toews; M D Burdick; M B Boyd; K S McAllister; R A McDonald; S L Kunkel; R M Strieter
Journal:  J Immunol       Date:  1996-11-15       Impact factor: 5.422

4.  Effect of isolation protocol on eosinophil function: Percoll gradients versus immunomagnetic beads.

Authors:  J B Sedgwick; Y Shikama; M Nagata; K Brener; W W Busse
Journal:  J Immunol Methods       Date:  1996-10-30       Impact factor: 2.303

5.  Eosinophils bind rhinovirus and activate virus-specific T cells.

Authors:  Z T Handzel; W W Busse; J B Sedgwick; R Vrtis; W M Lee; E A Kelly; J E Gern
Journal:  J Immunol       Date:  1998-02-01       Impact factor: 5.422

6.  Involvement of nitric oxide in protecting mechanism during experimental cryptococcosis.

Authors:  G R Rossi; L A Cervi; M M García; L S Chiapello; D A Sastre; D T Masih
Journal:  Clin Immunol       Date:  1999-02       Impact factor: 3.969

7.  Encapsulation of Cryptococcus neoformans with glucuronoxylomannan inhibits the antigen-presenting capacity of monocytes.

Authors:  C Retini; A Vecchiarelli; C Monari; F Bistoni; T R Kozel
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

8.  Epidemiological evidence for dormant Cryptococcus neoformans infection.

Authors:  D Garcia-Hermoso; G Janbon; F Dromer
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

9.  Eosinophil-Cryptococcus neoformans interactions in vivo and in vitro.

Authors:  M Feldmesser; A Casadevall; Y Kress; G Spira; A Orlofsky
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

10.  Localization of eosinophil granule major basic protein in paracoccidioidomycosis lesions.

Authors:  J M Wagner; M Franco; G M Kephart; G J Gleich
Journal:  Am J Trop Med Hyg       Date:  1998-07       Impact factor: 2.345

View more
  20 in total

Review 1.  The Eosinophil in Infection.

Authors:  Karen A Ravin; Michael Loy
Journal:  Clin Rev Allergy Immunol       Date:  2016-04       Impact factor: 8.667

Review 2.  Innate host defenses against Cryptococcus neoformans.

Authors:  Camaron Hole; Floyd L Wormley
Journal:  J Microbiol       Date:  2016-02-27       Impact factor: 3.422

3.  IL-23 dampens the allergic response to Cryptococcus neoformans through IL-17-independent and -dependent mechanisms.

Authors:  Wendy A Szymczak; Rani S Sellers; Liise-anne Pirofski
Journal:  Am J Pathol       Date:  2012-02-16       Impact factor: 4.307

Review 4.  The intracellular life of Cryptococcus neoformans.

Authors:  Carolina Coelho; Anamelia L Bocca; Arturo Casadevall
Journal:  Annu Rev Pathol       Date:  2013-09-16       Impact factor: 23.472

5.  Eosinophils contribute to IL-4 production and shape the T-helper cytokine profile and inflammatory response in pulmonary cryptococcosis.

Authors:  Daniel Piehler; Werner Stenzel; Andreas Grahnert; Josephin Held; Lydia Richter; Gabriele Köhler; Tina Richter; Maria Eschke; Gottfried Alber; Uwe Müller
Journal:  Am J Pathol       Date:  2011-05-31       Impact factor: 4.307

6.  Eosinophils elicit proliferation of naive and fungal-specific cells in vivo so enhancing a T helper type 1 cytokine profile in favour of a protective immune response against Cryptococcus neoformans infection.

Authors:  Ana P Garro; Laura S Chiapello; Jose L Baronetti; Diana T Masih
Journal:  Immunology       Date:  2011-10       Impact factor: 7.397

7.  Humoral Immunity Provides Resident Intestinal Eosinophils Access to Luminal Antigen via Eosinophil-Expressed Low-Affinity Fcγ Receptors.

Authors:  Kalmia M Smith; Raiann S Rahman; Lisa A Spencer
Journal:  J Immunol       Date:  2016-09-28       Impact factor: 5.422

8.  Impact of surfactant protein D, interleukin-5, and eosinophilia on Cryptococcosis.

Authors:  Stephanie M Holmer; Kathy S Evans; Yohannes G Asfaw; Divey Saini; Wiley A Schell; Julie G Ledford; Richard Frothingham; Jo Rae Wright; Gregory D Sempowski; John R Perfect
Journal:  Infect Immun       Date:  2013-11-25       Impact factor: 3.441

Review 9.  Eosinophils as Major Player in Type 2 Inflammation: Autoimmunity and Beyond.

Authors:  Marco Folci; Giacomo Ramponi; Ivan Arcari; Aurora Zumbo; Enrico Brunetta
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

10.  Experimental models of cryptococcosis.

Authors:  Wilber Sabiiti; Robin C May; E Rhiannon Pursall
Journal:  Int J Microbiol       Date:  2011-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.